These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1356053

  • 1. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E, Schmidt-Gayk H, Sinn HP, O'Connor DT, Raue F.
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [Abstract] [Full Text] [Related]

  • 2. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
    Raue F, Blind E, Grauer A.
    Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
    Blind E, Raue F, Klaiber T, Zink A, Schroth J, Buhr H, Ziegler R.
    J Endocrinol Invest; 1992 Feb; 15(2):93-8. PubMed ID: 1569295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L, Lombardi G, Colao A, Faggiano A.
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [Abstract] [Full Text] [Related]

  • 9. A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.
    O'Connell JE, Dominiczak AF, Isles CG, McLellan AR, Davidson G, Gray CE, Connell JM.
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):417-21. PubMed ID: 1971777
    [Abstract] [Full Text] [Related]

  • 10. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC.
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [Abstract] [Full Text] [Related]

  • 11. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R, Campos JM, Salaün C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
    Schott M, Willenberg HS, Sagert C, Nguyen TB, Schinner S, Cohnen M, Cupisti K, Eisenberger CF, Knoefel WT, Scherbaum WA.
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K, Kaznowski J, Klimowicz A, Maciejewski A, Łapińska-Cwojdzińska D, Gurgul E, Car AD, Fichna M, Gut P, Gryczyńska M, Ruchała M.
    Endokrynol Pol; 2017 Mar; 68(4):434-437. PubMed ID: 28585679
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
    Wang TS, Ocal IT, Sosa JA, Cox H, Roman S.
    Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.